192 related articles for article (PubMed ID: 27981609)
1. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.
Yan FJ; Zhang XJ; Wang WX; Ji YX; Wang PX; Yang Y; Gong J; Shen LJ; Zhu XY; Huang Z; Li H
Hepatology; 2017 May; 65(5):1492-1511. PubMed ID: 27981609
[TBL] [Abstract][Full Text] [Related]
2. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways.
Tao Q; Tianyu W; Jiangqiao Z; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z
Int J Biol Sci; 2019; 15(8):1618-1629. PubMed ID: 31360105
[TBL] [Abstract][Full Text] [Related]
3. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
[TBL] [Abstract][Full Text] [Related]
4. Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats.
Zhang Y; Wan J; Xu Z; Hua T; Sun Q
J Cell Physiol; 2019 May; 234(5):7467-7474. PubMed ID: 30367484
[TBL] [Abstract][Full Text] [Related]
5. TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.
Liu D; Zhang P; Zhou J; Liao R; Che Y; Gao MM; Sun J; Cai J; Cheng X; Huang Y; Chen G; Nie H; Ji YX; Zhang XJ; Huang Z; Xu H; She ZG; Li H
Cell Metab; 2020 Apr; 31(4):726-740.e8. PubMed ID: 32268115
[TBL] [Abstract][Full Text] [Related]
6. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
[TBL] [Abstract][Full Text] [Related]
7. Tripartite Motif 8 (TRIM8) Positively Regulates Pro-inflammatory Responses in Pseudomonas aeruginosa-Induced Keratitis Through Promoting K63-Linked Polyubiquitination of TAK1 Protein.
Guo L; Dong W; Fu X; Lin J; Dong Z; Tan X; Zhang T
Inflammation; 2017 Apr; 40(2):454-463. PubMed ID: 27995356
[TBL] [Abstract][Full Text] [Related]
8. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
[TBL] [Abstract][Full Text] [Related]
9. Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination.
Li Q; Yan J; Mao AP; Li C; Ran Y; Shu HB; Wang YY
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19341-6. PubMed ID: 22084099
[TBL] [Abstract][Full Text] [Related]
10. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
11. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.
Zhang QY; Zhao LP; Tian XX; Yan CH; Li Y; Liu YX; Wang PX; Zhang XJ; Han YL
Hepatology; 2017 Sep; 66(3):834-854. PubMed ID: 28508477
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.
Wang J; Ma J; Nie H; Zhang XJ; Zhang P; She ZG; Li H; Ji YX; Cai J
Hepatology; 2021 Jan; 73(1):104-125. PubMed ID: 32191345
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.
Ji YX; Huang Z; Yang X; Wang X; Zhao LP; Wang PX; Zhang XJ; Alves-Bezerra M; Cai L; Zhang P; Lu YX; Bai L; Gao MM; Zhao H; Tian S; Wang Y; Huang ZX; Zhu XY; Zhang Y; Gong J; She ZG; Li F; Cohen DE; Li H
Nat Med; 2018 Feb; 24(2):213-223. PubMed ID: 29291351
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
[TBL] [Abstract][Full Text] [Related]
17. F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice.
Bai L; Chen MM; Chen ZD; Zhang P; Tian S; Zhang Y; Zhu XY; Liu Y; She ZG; Ji YX; Li H
Hepatology; 2019 Dec; 70(6):1942-1957. PubMed ID: 30703849
[TBL] [Abstract][Full Text] [Related]
18. Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1.
Wang L; Zhang X; Lin ZB; Yang PJ; Xu H; Duan JL; Ruan B; Song P; Liu JJ; Yue ZS; Fang ZQ; Hu H; Liu Z; Huang XL; Yang L; Tian S; Tao KS; Han H; Dou KF
Cell Metab; 2021 Jul; 33(7):1372-1388.e7. PubMed ID: 34146477
[TBL] [Abstract][Full Text] [Related]
19. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
20. Elovl6 promotes nonalcoholic steatohepatitis.
Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H
Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
